Paper36946278
Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.
Gunn CM and 6 others. Cancer Control, 2023. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care. Papers, record 36946278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36946278
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Testing | Major topic |
| Prostatic Neoplasms | Major topic |
| Male | |
| Humans | |
| Health Services Accessibility |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23569316 | Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23569316 | PubMed |
| 2 | 29882171 | Current Approaches to Cancer Genetic Counseling Services for Spanish-Speaking Patients. | J Immigr Minor Health | 2019 | https://conductscience.org/library/papers/29882171 | PubMed |
| 3 | 34662201 | Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/34662201 | PubMed |
| 4 | 33629958 | Barriers and Facilitators to Genetic Service Delivery Models: Scoping Review. | Interact J Med Res | 2021 | https://conductscience.org/library/papers/33629958 | PubMed |
| 5 | 28619604 | Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions. | J Pharm Sci | 2017 | https://conductscience.org/library/papers/28619604 | PubMed |
| 6 | 34288206 | Spanish language concordance in genetic counseling sessions in the United States: Counselor experiences and perceptions of its effects on processes and outcomes. | J Genet Couns | 2022 | https://conductscience.org/library/papers/34288206 | PubMed |
| 7 | 31951474 | Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer. | JCO Clin Cancer Inform | 2020 | https://conductscience.org/library/papers/31951474 | PubMed |
| 8 | 33056955 | Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity - United States, 2001-2017. | MMWR Morb Mortal Wkly Rep | 2020 | https://conductscience.org/library/papers/33056955 | PubMed |
| 9 | 34775478 | Disparities in germline testing among racial minorities with prostate cancer. | Prostate Cancer Prostatic Dis | 2022 | https://conductscience.org/library/papers/34775478 | PubMed |
| 10 | 34257423 | Challenges in genetic testing: clinician variant interpretation processes and the impact on clinical care. | Genet Med | 2021 | https://conductscience.org/library/papers/34257423 | PubMed |
| 11 | 32343890 | Olaparib for Metastatic Castration-Resistant Prostate Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32343890 | PubMed |
| 12 | 31675070 | Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments. | J Natl Cancer Inst | 2020 | https://conductscience.org/library/papers/31675070 | PubMed |
| 13 | 34426665 | The design, implementation, and effectiveness of intervention strategies aimed at improving genetic referral practices: a systematic review of the literature. | Genet Med | 2021 | https://conductscience.org/library/papers/34426665 | PubMed |
| 14 | 20410767 | Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. | Obstet Gynecol | 2010 | https://conductscience.org/library/papers/20410767 | PubMed |
| 15 | 30730411 | Bringing Prostate Cancer Germline Genetics into Clinical Practice. | J Urol | 2019 | https://conductscience.org/library/papers/30730411 | PubMed |
| 16 | 29052810 | Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study. | J Genet Couns | 2018 | https://conductscience.org/library/papers/29052810 | PubMed |
| 17 | 35012874 | Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice. | Clin Genitourin Cancer | 2022 | https://conductscience.org/library/papers/35012874 | PubMed |
| 18 | 32955174 | Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32955174 | PubMed |
| 19 | 30730552 | Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/30730552 | PubMed |
| 20 | 10654830 | The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. | Health Serv Res | 2000 | https://conductscience.org/library/papers/10654830 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42842178 | Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42842178 | PubMed |
| 42718649 | Assessment of local provider engagement of an in-home collaborative model for remote genetic services. | Genet Med Open | 2026 | https://conductscience.org/library/papers/42718649 | PubMed |
| 42613122 | Scoping review of Australian prioritisation frameworks impacting consumer access to clinical genetics: protocol. | BMJ Open | 2026 | https://conductscience.org/library/papers/42613122 | PubMed |
| 41911491 | Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients. | Prostate | 2026 | https://conductscience.org/library/papers/41911491 | PubMed |
| 41653022 | Consumer acceptability of a cancer registry-driven familial cancer testing pathway: a qualitative study using the Theoretical Framework of Acceptability. | Future Oncol | 2026 | https://conductscience.org/library/papers/41653022 | PubMed |
| 40398351 | Germline testing for prostate cancer: current state and opportunities for enhanced access. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40398351 | PubMed |
| 40374330 | A Multi-Level Analysis of Barriers and Promoting Factors to Cascade Screening Uptake Among Male Relatives of BRCA1/2 Carriers: A Qualitative Study. | Psychooncology | 2025 | https://conductscience.org/library/papers/40374330 | PubMed |
| 40223139 | Oncogenic gene fusions in cancer: from biology to therapy. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40223139 | PubMed |
| 39579980 | Disparities in Genetic Testing for Inborn Errors of Immunity. | J Allergy Clin Immunol Pract | 2025 | https://conductscience.org/library/papers/39579980 | PubMed |
| 39484797 | Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: A mixed methods study. | Genet Med | 2025 | https://conductscience.org/library/papers/39484797 | PubMed |
| 39301117 | Utility of pembrolizumab for metastatic castrate resistant prostate cancer with MMR deficiency. | Urol Case Rep | 2024 | https://conductscience.org/library/papers/39301117 | PubMed |
| 38928323 | The Impact of Polymerase Chain Reaction Urine Testing on Clinical Decision-Making in the Management of Complex Urinary Tract Infections. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928323 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| CYCSP10 | 360166 | PubTator's text mining | https://conductscience.org/library/genes/360166 | NCBI Gene |
| CYCSP12 | 360168 | PubTator's text mining | https://conductscience.org/library/genes/360168 | NCBI Gene |
| CYCSP55 | 157317 | PubTator's text mining | https://conductscience.org/library/genes/157317 | NCBI Gene |
| PLAG1 | 5324 | PubTator's text mining | https://conductscience.org/library/genes/5324 | NCBI Gene |
| PTPN6 | 5777 | PubTator's text mining | https://conductscience.org/library/genes/5777 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36946278
GET https://conductscience.org/api/papers/v1/36946278/references?page=2